Ticlopidine
Ticlopidine has been discontinued due to severe and life-threatening blood and bone marrow side effects, combined with the availability of safer, better-tolerated alternatives like clopidogrel.
This drug acted by blocking the platelet ADP receptor, which promotes aggregation when activated. It had previously been used in the UK, in combination with aspirin, to prevent thrombosis with coronary stents.
Related pages
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page